Etherna Immunotherapies (SA)

Active
VAT

BE 0502.703.389

Address
Galileilaan 19
2845 Niel
Established
21-01-2013
Principal activity
Other research and experimental development on natural sciences and engineering

Crisis resilience of Etherna Immunotherapies

Which companies are best armed against current economic trends and the energy crisis?

Read more

Financial data of Etherna Immunotherapies

2023 Financial statements 2022 Financial statements 2021 Financial statements 2020 Financial statements
Turnover €6,796,302
65%
€4,111,500
-
-
-
-
Profit/Loss -€10,679,614
42%
-€18,453,870
-8%
-€17,125,124
-4%
-€16,507,176
Equity €6,973,378
-60%
€17,652,992
564%
-€3,801,412
< -1.000%
€323,841
Gross margin €520,707
-36%
€810,482
-81%
€4,314,550
676%
€556,273
Employees 68,6 FTE
7%
64,1 FTE
4%
61,4 FTE
47%
41,9 FTE

Frequently asked questions

What is the VAT number of Etherna Immunotherapies?
The VAT number of Etherna Immunotherapies is BE0502703389.
When was Etherna Immunotherapies founded?
Etherna Immunotherapies was founded on 21-01-2013.
What is the address of Etherna Immunotherapies?
The current registered office of Etherna Immunotherapies is located at Galileilaan 19, 2845 Niel.
When was the last time Etherna Immunotherapies filed their annual financial statements?
The most recent financial statements of Etherna Immunotherapies were filed on 09-05-2024. You can view them here.
How many employees does Etherna Immunotherapies have?
There are 68,6 FTEs working at Etherna Immunotherapies according to the staff figures in the most recent financial statements.
What is the annual turnover of Etherna Immunotherapies?
At the time of its most recent financial statements, Etherna Immunotherapies recorded a total turnover of €6,796,302.50.
Address

  You have disabled Javascript on your computer. To use this website, please enable Javascript first.


More details